Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Crown Bioscience Appoints GM | Contract Pharma
Promotions & Moves

Crown Bioscience Appoints GM

Thatte to head up the company's center of excellence in San Diego

Dr. Jayant Thatte has been appointed general manager at Crown Bioscience to head up the company’s center of excellence in San Diego.  

Dr. Thatte is an immunologist with 20 years of research experience in both academia and industry, focusing on cancer, autoimmunity, inflammation and pain. As director of R&D and associate director of operations at Molecular Response, he led the pharmacology team for numerous client projects that increased revenue growth, which ultimately resulted in Crown Bioscience’s acquisition of PDX.

Michael Prosser, vice president of CrownBio’s European and North American operations, said, “Dr. Thatte brings established leadership and decades of research experience to the General Manager role. As COO of CrownBio San Diego, Jayant has played a central role in the site’s recent growth and success, leading the teams to deliver PDX, syngeneic, cell-line xenograft, and humanized PDX/xenograft platforms, supporting both immuno-oncology and targeted therapy programs for our clients.”

Dr. Jean Pierre Wery, chief executive officer of CrownBio, added, “CrownBio invests in our teams’ leadership development and succession plans so that dedicated individuals, such as Thatte, are ready to step up and into new roles when needed and to support sustained growth.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters